当前位置:首页 - 行情中心 - 润达医疗(603108) - 财务分析

润达医疗

(603108)

  

流通市值:93.93亿  总市值:93.93亿
流通股本:6.04亿   总股本:6.04亿

润达医疗(603108)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-1.26亿元,每股收益-0.27元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益534374.65万元,未分配利润215493.32万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1391619.95万元,负债857245.30万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入5,268,459,587.793,470,487,876.091,661,846,010.138,311,780,357.39
营业总成本5,307,471,760.123,514,567,613.81,695,369,724.197,994,783,190.57
其他经营收益
营业利润-57,510,244.93-51,489,772.36-49,107,278.75354,059,846.36
利润总额-61,787,787.5-53,060,475.47-48,726,246.72345,542,198.88
净利润-126,203,563.8-99,482,170.05-67,863,002.26189,458,021.05
每股收益
其他综合收益-285,439.17-1,094,094.8861,323.972,915,308.12
综合收益总额-126,489,002.97-100,576,264.93-67,801,678.29192,373,329.17
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计8,839,207,893.188,737,915,173.38,944,695,039.639,203,020,127.92
非流动资产:
非流动资产合计5,076,991,623.965,050,672,227.895,094,706,515.565,102,522,533.62
资产总计13,916,199,517.1413,788,587,401.1914,039,401,555.1914,305,542,661.54
流动负债:
流动负债合计7,362,842,574.067,239,624,168.077,293,690,057.767,544,031,599.78
非流动负债:
非流动负债合计1,209,610,411.081,167,482,510.431,270,432,209.121,157,364,153.01
负债合计8,572,452,985.148,407,106,678.58,564,122,266.888,701,395,752.79
所有者权益(或股东权益):
归属于母公司股东权益合计4,174,991,087.744,216,107,828.514,285,970,376.964,354,582,007.41
股东权益合计5,343,746,5325,381,480,722.695,475,279,288.315,604,146,908.75
负债和股东权益合计13,916,199,517.1413,788,587,401.1914,039,401,555.1914,305,542,661.54
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计6,337,329,716.414,199,733,674.282,103,042,784.869,810,807,577.03
经营活动现金流出小计5,898,385,564.484,045,937,031.981,986,373,242.969,163,860,197.32
经营活动产生的现金流量净额438,944,151.93153,796,642.3116,669,541.9646,947,379.71
投资活动产生的现金流量:
投资活动现金流入小计359,742,152.69206,096,508.8965,681,216.01419,260,002.9
投资活动现金流出小计502,664,403.12193,393,692.3779,737,229.11879,926,149.67
投资活动产生的现金流量净额-142,922,250.4312,702,816.52-14,056,013.1-460,666,146.77
筹资活动产生的现金流量:
筹资活动现金流入小计5,867,205,068.234,050,977,242.911,648,589,033.210,031,941,723.55
筹资活动现金流出小计6,359,901,404.174,453,536,155.931,957,852,000.629,939,642,810.42
筹资活动产生的现金流量净额-492,696,335.94-402,558,913.02-309,262,967.4292,298,913.13
汇率变动对现金及现金等价物的影响226,848.13,570,941.43-221,319.15-2,856,562.25
现金及现金等价物净增加额-196,447,586.34-232,488,512.77-206,870,757.77275,723,583.82
期末现金及现金等价物余额692,563,698.77656,522,772.34682,194,527.34889,011,285.11
补充资料:
现金及现金等价物的净增加额--232,488,512.77-275,723,583.82
最新报告期:2025-09-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华安证券谭国超0.330.400.462025-09-08
TOP↑